Clinical Trials Insight: 700035336

Trial Profile

Clinical Trials Insight: 700035336

Planning
Phase of Trial: Phase I

Latest Information Update: 07 Jan 2009

At a glance

  • Drugs IQP 0410 (Primary)
  • Indications HIV infections
  • Focus Adverse reactions
  • Sponsors ImQuest Life Sciences
  • Most Recent Events

    • 07 Jan 2009 An IND application has been submitted to the US FDA, as reported by ImQuest Life Sciences. The trial is expected to begin in Q1 2009.
    • 16 Jul 2008 New trial record.
    • 09 Jul 2008 ImQuest Life Sciences plans to submit an Investigational New Drug application for IQP 0410 in the third quarter of 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top